Creative Planning
AMED

Creative Planning’s Amedisys AMED Stock Holding History

Creative Planning’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,817
Closed -$3.92M – 3912
2025
Q2 		$3.92M Buy
39,817
+26,548
+200% +$2.51M ﹤0.01% 880
2025
Q1 		$1.23M Buy
13,269
+4,126
+45% +$380K ﹤0.01% 1544
2024
Q4 		$830K Buy
9,143
+4,305
+89% +$395K ﹤0.01% 1796
2024
Q3 		$467K Buy
4,838
+543
+13% +$53K ﹤0.01% 2168
2024
Q2 		$394K Buy
4,295
+295
+7% +$27.4K ﹤0.01% 2141
2024
Q1 		$369K Buy
4,000
+694
+21% +$65K ﹤0.01% 2084
2023
Q4 		$314K Sell
3,306
-175
-5% -$16.3K ﹤0.01% 2059
2023
Q3 		$325K Sell
3,481
-74
-2% -$6.84K ﹤0.01% 1866
2023
Q2 		$325K Buy
3,555
+632
+22% +$51.8K ﹤0.01% 1845
2023
Q1 		$215K Buy
2,923
+262
+10% +$22.7K ﹤0.01% 2074
2022
Q4 		$222K Buy
2,661
+574
+28% +$51.8K ﹤0.01% 1949
2022
Q3 		$202K Buy
2,087
+1,581
+312% +$189K ﹤0.01% 1908
2022
Q2 		$53K Sell
506
-1,377
-73% -$176K ﹤0.01% 2043
2022
Q1 		$324K Sell
1,883
-30
-2% -$4.48K ﹤0.01% 1582
2021
Q4 		$310K Sell
1,913
-15
-0.8% -$2.41K ﹤0.01% 1597
2021
Q3 		$287K Sell
1,928
-243
-11% -$50.5K ﹤0.01% 1620
2021
Q2 		$532K Buy
2,171
+250
+13% +$65.6K ﹤0.01% 1243
2021
Q1 		$509K Sell
1,921
-81
-4% -$22.8K ﹤0.01% 1428
2020
Q4 		$587K Buy
2,002
+26
+1% +$6.67K ﹤0.01% 1223
2020
Q3 		$467K Buy
1,976
+24
+1% +$5.46K ﹤0.01% 1170
2020
Q2 		$387K Hold
1,952
– – ﹤0.01% 1167
2020
Q1 		$358K Sell
1,952
-41
-2% -$7.29K ﹤0.01% 1105
2019
Q4 		$333K Buy
1,993
+55
+3% +$8.18K ﹤0.01% 1344
2019
Q3 		$254K Sell
1,938
-224
-10% -$29.2K ﹤0.01% 1466
2019
Q2 		$263K Hold
2,162
– – ﹤0.01% 1453
2019
Q1 		$267K Sell
2,162
-102
-5% -$12.8K ﹤0.01% 1395
2018
Q4 		$265K Buy
2,264
+207
+10% +$24.4K ﹤0.01% 1312
2018
Q3 		$257K Buy
+2,057
New +$227K ﹤0.01% 1506
2017
Q3 		– Sell
-1,000
Closed -$63K – 1950
2017
Q2 		$63K Hold
1,000
– – ﹤0.01% 2326
2017
Q1 		$51K Hold
1,000
– – ﹤0.01% 2458
2016
Q4 		$43K Sell
1,000
-56
-5% -$2.38K ﹤0.01% 2505
2016
Q3 		$50K Sell
1,056
-40
-4% -$2K ﹤0.01% 2352
2016
Q2 		$55K Sell
1,096
-20
-2% -$1.01K ﹤0.01% 2072
2016
Q1 		$54K Buy
1,116
+40
+4% +$1.54K ﹤0.01% 2038
2015
Q4 		$42K Buy
1,076
+10
+0.9% +$400 ﹤0.01% 2250
2015
Q3 		$40K Buy
+1,066
New +$45K ﹤0.01% 2192
2015
Q2 		– Sell
-1,964
Closed -$53K – 1172
2015
Q1 		$53K Sell
1,964
-188
-9% -$5.3K ﹤0.01% 1991
2014
Q4 		$63K Buy
2,152
+490
+29% +$12.1K ﹤0.01% 1841
2014
Q3 		$34K Buy
1,662
+460
+38% +$8.88K ﹤0.01% 2174
2014
Q2 		$20K Hold
1,202
– – ﹤0.01% 2473
2014
Q1 		$18K Buy
1,202
+800
+199% +$12.3K ﹤0.01% 2433
2013
Q4 		$6K Sell
402
-1,200
-75% -$19.3K ﹤0.01% 2756
2013
Q3 		$28K Sell
1,602
-200
-11% -$2.97K ﹤0.01% 1884
2013
Q2 		$21K Buy
+1,802
New +$20.6K ﹤0.01% 1893

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Creative Planning's AMED Position: Q3 2025 in Review

Creative Planning sold out of Amedisys (AMED) in Q3 2025, closing a stake of 39,817 shares — an estimated $3.92M sold.

Creative Planning first reported a position in AMED in Q2 2013 and held it in 44 quarters. The position peaked at $3.92M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Creative Planning reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Creative Planning sold 39,817 Amedisys shares in Q3 2025, an estimated $3.92M.
  • Creative Planning first reported a position in Amedisys in Q2 2013 and held it in 44 quarters.
  • Creative Planning's Amedisys position peaked at $3.92M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.